Definitive Contract 75F40119C10071

Award Date 8/12/19
Potential Completion Date 2/18/20
Potential Value $377K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,539,788.80 firm-fixed price definitive contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the scale-up of an existing Medical Device Evaluation (MDE) Artificial Intelligence (AI) pilot to an operational tool. ICA has an extensive track record supporting federal health agencies like HHS and...
This contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $4,224,342.40 Firm Fixed Price Definitive Contract is for CDRH MDE AI PRESCRIPTIVE ANALYTICS services, with an ultimate completion date of September 24, 2024. The contract was awarded as an 8(a) Sole Source. ICA is a specialized provider of advanced data analytics, artificial...
This is a $4,174,814.40 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of an artificial intelligence (AI) tool to predict alerts related to medical devices under the Center for Devices and Radiological Health (CDRH). This sole-source, 8(a) set-aside contract will run through September 24, 2024. ICA is...
This is a $4,294,646.40 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA) to develop a Center for Devices and Radiological Health (CDRH) Medical Device AI Data Lake with Real-World Data. ICA is an SBA-certified 8(a), minority-owned, small disadvantaged business that specializes in healthcare data analytics, medical device evaluation, and AI solutions for federal health agencies. The contract has a firm fixed-price...
This is a $3,920,678.40 firm-fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of a medical device predictive analytics tool to support the FDA's regulatory decision-making processes. The contract is an 8(a) sole source award, which means it was set aside for eligible 8(a) program...
The Food and Drug Administration (FDA) awarded a $3,821,128.80 firm-fixed-price contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. This contract is part of the FDA's Center for Devices and Radiological Health's (CDRH) Medical Data Enterprise Initiative, which aims to streamline the use of real-world data and integrate it with CDRH data. ICA will provide advanced data analytics, artificial intelligence, healthcare...
This is a sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA) for $98,783.16 to provide consulting services for research to evaluate electronic health record (EHR) data quality for the Center for Devices and Radiological Health (CDRH). The contract has a firm fixed price and an ultimate completion date of December 5, 2020. ICA is an SBA-certified 8(a), minority-owned, small disadvantaged business that specializes in...
This $3,976,584.00 firm fixed price federal contract was awarded to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business, by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS). The 2-year contract, titled "CDRH REAL-WORLD DATA ANALYSES," is for ICA to provide advanced data analytics, artificial intelligence, healthcare IT, and management consulting services...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The $202,946.14 contract is for research to evaluate how the FDA's Center for Devices and Radiological Health (CDRH) assesses real-world evidence in regulatory submissions and identify best practices. ICA, a minority-owned small business, specializes in healthcare data...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price definitive contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business, to provide a natural language querying module for the Center for Devices and Radiological Health (CDRH). The $3,703,521.60 contract was awarded on September 14, 2022, with a completion date of March 19, 2024. ICA has extensive experience...

This is a sole source 8(a) contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business, for a landscape analysis to evaluate medical device data systems and real-world evidence for the use of artificial intelligence to detect device signals. The firm fixed price contract has a potential value of $377,048.80 and a completion date of February 18, 2020. ICA specializes in healthcare data analytics, artificial intelligence, medical device safety, and real-world evidence evaluation to support federal health initiatives. The company has provided similar services to HHS in the past, including predictive analytics, post-market medical device safety studies, and real-world data analysis.

Generated 3/23/24, 9:49 PM